POLYMORPHISM OF THE GENE OF β2-ADRENERGIC RECEPTOR AND EFFICIENCY OF THE BRONCHOLYTIC THERAPY AMONG CHILDREN WITH BRONCHIAL ASTHMA

The variability of the pharmacological response to β2-agonists may be due to the polymorphism of the gene of β2-adrenergic receptor (ADRβ2). The objective of our research was to evaluate the significance of ADRβ2 gene polymorphism in the 16th amino acid position in the efficiency of broncholytic the...

Full description

Saved in:
Bibliographic Details
Main Authors: O.N. Bryantseva, E.E. Tikhomirov, N.V. Zhurkova, N.I. Voznesenskaya, G.M. Bayazutdinova, N.S. Aver'yanova, I.I. Balabolkin, V.G. Pinelis
Format: Article
Language:Russian
Published: Union of pediatricians of Russia 2007-06-01
Series:Педиатрическая фармакология
Online Access:https://www.pedpharma.ru/jour/article/view/659
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839587246541373440
author O.N. Bryantseva
E.E. Tikhomirov
N.V. Zhurkova
N.I. Voznesenskaya
G.M. Bayazutdinova
N.S. Aver'yanova
I.I. Balabolkin
V.G. Pinelis
author_facet O.N. Bryantseva
E.E. Tikhomirov
N.V. Zhurkova
N.I. Voznesenskaya
G.M. Bayazutdinova
N.S. Aver'yanova
I.I. Balabolkin
V.G. Pinelis
author_sort O.N. Bryantseva
collection DOAJ
description The variability of the pharmacological response to β2-agonists may be due to the polymorphism of the gene of β2-adrenergic receptor (ADRβ2). The objective of our research was to evaluate the significance of ADRβ2 gene polymorphism in the 16th amino acid position in the efficiency of broncholytic therapy by β2-agonists agonists among children with bronchial asthma. We defined the type of ADRβ2 gene among 208 children with bronchial asthma of various severity by means of polymerase chain reaction. The distribution of the patients into two groups was carried out subject to the efficiency of the β2-agonists agonist based short term therapy during the exacerbation of bronchial asthma. 171 children received the inhaled glucocorticoids. The researchers singled out statistically significant differences of the genotype distribution. the gly/gly16 homozygous allele was discovered twice as often in the group with an insufficient response to β2-agonists agonists than in the group with a good response (66 v. 38%, р < 0,001), while in the distribution of the heterozygous allele the researchers uncovered the inverse pattern (55 v. 28%, р < 0,001). In the arg/arg16 genotype distribution, there were no considerable differences in both groups (6% in each group). In the subgroups of children, receiving the high doses of the inhaled glucocorticoids, the researchers traced the trend for the gly/gly16 homozygous allele prevalence. conclusions: we have discovered the association of the gly/gly16 genotype of the ADRβ2 gene with an insufficient effect of broncholytic therapy by means of short term β2-agonists agonists; we also revealed the participation of the gly16 allele in the phenotype formation with the severe run of bronchial asthma and to lerance towards the therapy both by β2-agonists agonists and inhaled glucocorticoids.Key words: bronchial asthma, β2-adrenergic receptor, children, treatment.
format Article
id doaj-art-fd2ec35bb33b490fb8daf38e7f2c09d4
institution Matheson Library
issn 1727-5776
2500-3089
language Russian
publishDate 2007-06-01
publisher Union of pediatricians of Russia
record_format Article
series Педиатрическая фармакология
spelling doaj-art-fd2ec35bb33b490fb8daf38e7f2c09d42025-08-03T19:21:19ZrusUnion of pediatricians of RussiaПедиатрическая фармакология1727-57762500-30892007-06-01433539655POLYMORPHISM OF THE GENE OF β2-ADRENERGIC RECEPTOR AND EFFICIENCY OF THE BRONCHOLYTIC THERAPY AMONG CHILDREN WITH BRONCHIAL ASTHMAO.N. Bryantseva0E.E. Tikhomirov1N.V. Zhurkova2N.I. Voznesenskaya3G.M. Bayazutdinova4N.S. Aver'yanova5I.I. Balabolkin6V.G. Pinelis7Scientific Center of Children Health, Russian Academy of Medical Sciences, MoscowScientific Center of Children Health, Russian Academy of Medical Sciences, MoscowScientific Center of Children Health, Russian Academy of Medical Sciences, MoscowScientific Center of Children Health, Russian Academy of Medical Sciences, MoscowScientific Center of Children Health, Russian Academy of Medical Sciences, MoscowScientific Center of Children Health, Russian Academy of Medical Sciences, MoscowScientific Center of Children Health, Russian Academy of Medical Sciences, MoscowScientific Center of Children Health, Russian Academy of Medical Sciences, MoscowThe variability of the pharmacological response to β2-agonists may be due to the polymorphism of the gene of β2-adrenergic receptor (ADRβ2). The objective of our research was to evaluate the significance of ADRβ2 gene polymorphism in the 16th amino acid position in the efficiency of broncholytic therapy by β2-agonists agonists among children with bronchial asthma. We defined the type of ADRβ2 gene among 208 children with bronchial asthma of various severity by means of polymerase chain reaction. The distribution of the patients into two groups was carried out subject to the efficiency of the β2-agonists agonist based short term therapy during the exacerbation of bronchial asthma. 171 children received the inhaled glucocorticoids. The researchers singled out statistically significant differences of the genotype distribution. the gly/gly16 homozygous allele was discovered twice as often in the group with an insufficient response to β2-agonists agonists than in the group with a good response (66 v. 38%, р < 0,001), while in the distribution of the heterozygous allele the researchers uncovered the inverse pattern (55 v. 28%, р < 0,001). In the arg/arg16 genotype distribution, there were no considerable differences in both groups (6% in each group). In the subgroups of children, receiving the high doses of the inhaled glucocorticoids, the researchers traced the trend for the gly/gly16 homozygous allele prevalence. conclusions: we have discovered the association of the gly/gly16 genotype of the ADRβ2 gene with an insufficient effect of broncholytic therapy by means of short term β2-agonists agonists; we also revealed the participation of the gly16 allele in the phenotype formation with the severe run of bronchial asthma and to lerance towards the therapy both by β2-agonists agonists and inhaled glucocorticoids.Key words: bronchial asthma, β2-adrenergic receptor, children, treatment.https://www.pedpharma.ru/jour/article/view/659
spellingShingle O.N. Bryantseva
E.E. Tikhomirov
N.V. Zhurkova
N.I. Voznesenskaya
G.M. Bayazutdinova
N.S. Aver'yanova
I.I. Balabolkin
V.G. Pinelis
POLYMORPHISM OF THE GENE OF β2-ADRENERGIC RECEPTOR AND EFFICIENCY OF THE BRONCHOLYTIC THERAPY AMONG CHILDREN WITH BRONCHIAL ASTHMA
Педиатрическая фармакология
title POLYMORPHISM OF THE GENE OF β2-ADRENERGIC RECEPTOR AND EFFICIENCY OF THE BRONCHOLYTIC THERAPY AMONG CHILDREN WITH BRONCHIAL ASTHMA
title_full POLYMORPHISM OF THE GENE OF β2-ADRENERGIC RECEPTOR AND EFFICIENCY OF THE BRONCHOLYTIC THERAPY AMONG CHILDREN WITH BRONCHIAL ASTHMA
title_fullStr POLYMORPHISM OF THE GENE OF β2-ADRENERGIC RECEPTOR AND EFFICIENCY OF THE BRONCHOLYTIC THERAPY AMONG CHILDREN WITH BRONCHIAL ASTHMA
title_full_unstemmed POLYMORPHISM OF THE GENE OF β2-ADRENERGIC RECEPTOR AND EFFICIENCY OF THE BRONCHOLYTIC THERAPY AMONG CHILDREN WITH BRONCHIAL ASTHMA
title_short POLYMORPHISM OF THE GENE OF β2-ADRENERGIC RECEPTOR AND EFFICIENCY OF THE BRONCHOLYTIC THERAPY AMONG CHILDREN WITH BRONCHIAL ASTHMA
title_sort polymorphism of the gene of β2 adrenergic receptor and efficiency of the broncholytic therapy among children with bronchial asthma
url https://www.pedpharma.ru/jour/article/view/659
work_keys_str_mv AT onbryantseva polymorphismofthegeneofb2adrenergicreceptorandefficiencyofthebroncholytictherapyamongchildrenwithbronchialasthma
AT eetikhomirov polymorphismofthegeneofb2adrenergicreceptorandefficiencyofthebroncholytictherapyamongchildrenwithbronchialasthma
AT nvzhurkova polymorphismofthegeneofb2adrenergicreceptorandefficiencyofthebroncholytictherapyamongchildrenwithbronchialasthma
AT nivoznesenskaya polymorphismofthegeneofb2adrenergicreceptorandefficiencyofthebroncholytictherapyamongchildrenwithbronchialasthma
AT gmbayazutdinova polymorphismofthegeneofb2adrenergicreceptorandefficiencyofthebroncholytictherapyamongchildrenwithbronchialasthma
AT nsaveryanova polymorphismofthegeneofb2adrenergicreceptorandefficiencyofthebroncholytictherapyamongchildrenwithbronchialasthma
AT iibalabolkin polymorphismofthegeneofb2adrenergicreceptorandefficiencyofthebroncholytictherapyamongchildrenwithbronchialasthma
AT vgpinelis polymorphismofthegeneofb2adrenergicreceptorandefficiencyofthebroncholytictherapyamongchildrenwithbronchialasthma